Another post-stroke change involves upregulation of Alzheimer’s disease and related dementia (ADRD) biomarkers including amyloid beta (Aβ), tubulin associated unit (tau), and neurofilament light chain (NfL; Gustaw-Rothenberg et al., 2010). The gene discussed is MAPT; the disease is stroke disorder.